MIM Symphony HDR Prostate With Intra-Op MR Image Guidance Launched
GE HealthCare’s MIM Software introduced MIM Symphony HDR Prostate to support high dose-rate (HDR) brachytherapy. This solution aims to increase clinician confidence and help improve patient outcomes by providing direct tumor visualization from magnetic resonance imaging (MRI) scans during live ultrasound procedures for HDR prostate treatments.
MIM Symphony HDR Prostate corrects MRI orientation and offers MRI guidance during HDR prostate procedures.
Typically, clinicians use CT or ultrasound imaging for planning these procedures. Incorporating MRI into brachytherapy treatment planning can reduce toxicity to critical structures. However, the challenge of accurately aligning MRI contours with live ultrasound images has hindered the use of MRI in HDR treatments.
Dr Peter Rossi, MD, FABS, Chairman of the Board at the American Brachytherapy Society and Radiation Oncologist at Valley View Hospital, said, “I often get the question, what is the best imaging modality for planning HDR prostate procedures, ultrasound or CT? My response is always MRI. MRI guidance enables more confident, precise treatments and reduces toxicity to organs at risk. I’ve had the pleasure of providing my patients with precise treatments using MRI guidance in MIM Symphony HDR Prostate, and I look forward to other clinics having the same opportunity.”
GE HealthCare’s MIM Software developed MIM Symphony HDR Prostate to align contours on preoperatively acquired MRI with live ultrasound, providing clear visibility of the prostate, lesions, and critical structures during HDR prostate procedures. Aligning the MRI contours with the ultrasound assists clinicians in precise needle placement by:
- Defining the lesion and tracking changes to guide needle placement, even as the prostate moves during the procedure;
- Correcting differences between MRI supine and ultrasound lithotomy orientations with ReSlicer, a tool in MIM Symphony HDR Prostate; and
- Automatically digitizing needles on CT or ultrasound planning images as well as performing needle review and free length checks.
“Our goal with this solution is to empower clinicians to plan and deliver safe, more informed, and precise treatment for patients with prostate disease,” said Andrew Nelson, CEO of MIM Software, GE HealthCare. “MIM Symphony HDR Prostate exemplifies decades of MIM Software and GE HealthCare innovations that enable precision care, and we’re thrilled to expand our impact in brachytherapy.”
